News
Public · Published
Melius Research downgrades NVIDIA to Hold from Buy, lowers price target to $185 from $315
Melius Research downgraded NVIDIA from Buy to Hold and lowered its price target from $315 to $185, a 41.3% decrease. The new target implies 6.5% upside from NVIDIA's Nov. 11 closing price of $173.73.
Published:
Updated:
What happened
Melius Research downgraded NVIDIA from Buy to Hold and lowered its price target from $315 to $185, a 41.3% decrease. The new target implies 6.5% upside from NVIDIA’s Nov. 11 closing price of $173.73.
Confirmed
Global impact / market context
The downgrade and lower target could lead some investors to reduce NVIDIA share purchases or sell, putting pressure on the share price. A weaker share price could also make it harder for the company to raise funds by issuing shares, though the article reports no such response.
Analyst inference
The five recent analyst notes listed have targets from $180 to $280 and include Buy, Hold, Outperform, and Neutral ratings. Melius’s $185 target is near the low end, showing its view is more cautious than several listed peers.
Confirmed
What to watch
- Check whether later analyst notes lower their targets or ratings; broader cuts could reinforce cautious investor positioning and increase selling pressure on NVIDIA shares. Analyst inference
- Compare NVIDIA’s share price with the stated $173.73 Nov. 11 close, since the reported 6.5% implied upside is measured from that reference point. Analyst inference
- The listed recent targets range from $180 to $280, including a $180 Hold rating and a $280 Buy rating, providing direct points of comparison. Confirmed
Evidence
- Original source link unavailable